NFKB1 and psoriasis: Simultaneously, IDMF represses pro-inflammatory transcription factors, including NF-κB, AP-1, and potentially IRF1, leading to the downregulation of key psoriasis-associated cytokines such as IL-17A, IL-23A, IL-36G, and IFN-γ.